NovaGo Therapeutics Secures $30 Million Series B Financing to Enhance Spinal Cord Injury Research#Switzerland#Spinal_Cord_Injury#NovaGo_Therapeutics#Schlieren#Nogo-A_Biologics
NovaGo Therapeutics Secures $30 Million Series B Financing to Enhance Spinal Cord Injury Research
NovaGo Therapeutics has completed a $30 million Series B funding round aimed at advancing their clinical study for spinal cord injury treatment, pioneering innovative nerve regeneration solutions.
third-news.com
September 2, 2026 at 10:10 AM
NovaGo Therapeutics Secures $30 Million Series B Financing to Enhance Spinal Cord Injury Research#Switzerland#Spinal_Cord_Injury#NovaGo_Therapeutics#Schlieren#Nogo-A_Biologics